World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
63
Citations
14777
World Ranking
3018
National Ranking
73

Overview

Louis A. Matis is a researcher affiliated with Alexion Pharma (Switzerland) in Switzerland. Their work spans multiple areas within medicine, particularly focusing on oncology, immunology, pulmonary and respiratory medicine, and radiology.

The main fields of study covered by Louis A. Matis include:

  • Medicine

They have contributed to several subfields, including:

  • Radiology, Nuclear Medicine and Imaging
  • Oncology
  • Pulmonary and Respiratory Medicine
  • Physiology
  • Immunology

Research topics explored by Louis A. Matis encompass:

  • Monoclonal and Polyclonal Antibodies Research
  • HER2/EGFR in Cancer Research
  • Radiopharmaceutical Chemistry and Applications
  • Asthma and respiratory diseases
  • Inhalation and Respiratory Drug Delivery
  • Respiratory and Cough-Related Research
  • CAR-T cell therapy research

Some of their recent papers are:

  • O82 A phase 1 dose escalation study of PRS-343, a HER2/4-1BB bispecific molecule, in patients with HER2-positive malignancies, 2020, Oral Presentations
  • Elarekibep (PRS-060/AZD1402), a new class of inhaled Anticalin medicine targeting IL-4Ra for type 2 endotype asthma, 2022, Journal of Allergy and Clinical Immunology
  • 1060 EVOLVE™: a novel costimulatory T cell engager platform engineered for the treatment of immune suppressive tumors, 2022, Regular and Young Investigator Award Abstracts

Frequent coauthors collaborating with Louis A. Matis include:

  • Shane A. Olwill
  • Sarina A. Piha-Paul
  • Johanna C. Bendell
  • Anthony Tolcher
  • Sara A. Hurvitz

The main publication venues appearing in their recent work are:

  • Oral Presentations
  • Journal of Allergy and Clinical Immunology
  • Regular and Young Investigator Award Abstracts

Best Publications

  • The Role of Fas in Autoimmune Diabetes

    Alexander V Chervonsky;Yi Wang;F.Susan Wong;Irene Visintin

  • Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease

    Yi Wang;Scott A. Rollins;Joseph A. Madri;Louis A. Matis

  • The nature of major histocompatibility complex recognition by γδ T cells

    Hansjörg Schild;Nasim Mavaddat;Nasim Mavaddat;Christa Litzenberger;Elliot W. Ehrich

  • Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5

    Yi Wang;Qile Hu;Joseph A. Madri;Scott A. Rollins

  • Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv

    Thomas C. Thomas;Scott A. Rollins;Russell P. Rother;Michelle A. Giannoni

  • Myocardial Infarction and Apoptosis After Myocardial Ischemia and Reperfusion Role of the Terminal Complement Components and Inhibition by Anti-C5 Therapy

    Antti P. Vakeva;Azin Agah;Scott A. Rollins;Louis A. Matis

  • In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B.

    B L Rellahan;L A Jones;A M Kruisbeek;A M Fry

  • Correlations between T-cell specificity and the structure of the antigen receptor.

    Pamela J. Fink;Louis A. Matis;David L. McElligott;Michael Bookman

  • Pharmacology and Biological Efficacy of a Recombinant, Humanized, Single-Chain Antibody C5 Complement Inhibitor in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardiopulmonary Bypass

    Jane C. K. Fitch;Scott Rollins;Louis Matis;Bernadette Alford

  • Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection

    William L. Fodor;Barry L. Williams;Louis A. Matis;Joseph A. Madri

  • Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules

    Louis A. Matis;Laurie H. Glimcher;William E. Paul;Ronald H. Schwartz

  • Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling.

    L Racioppi;F Ronchese;L A Matis;R N Germain

  • Monoclonal antibody against an Ir gene product

    Ethan A. Lerner;Louis A. Matis;Charles A. Janeway;Patricia P. Jones

  • Composition and method for treating glomerulonephritis and other inflammatory diseases

    Mark J Evans;Louis Matis;Eileen Elliott Mueller;Steven H Nye

  • Major histocompatibility complex-linked specificity of γδ receptor-bearing T lymphocytes

    Louis A. Matis;Randy Cron;Jeffrey A. Bluestone

  • The Fine Specificity of Antigen and la Determinant Recognition by T Cell Hybridoma Clones Specific for Pigeon Cytochrome c

    Stephen M. Hedrick;Louis A. Matis;Toby T. Hecht;Lawrence E. Samelson

  • Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation.

    C. S. Rinder;H. M. Rinder;B. R. Smith;J. C. K. Fitch

  • A role for complement in antibody-mediated inflammation: C5 deficient DBA/1 mice are resistant to collagen-induced arthritis

    Yi Wang;Jane Kristan;Liming Hao;Catherine S. Lenkoski

  • Self-reactive γδ T cells are eliminated in the thymus

    Alexander L. Dent;Louis A. Matis;Farideh Hooshmand;Suzanne M. Widacki

  • Selection of amino acid sequences in the beta chain of the T cell antigen receptor

    Stephen M. Hedrick;Isaac Engel;David L. McElligott;Pamela J. Fink

Frequent Co-Authors

Russell P. Rother
Russell P. Rother Tetherex Pharmaceuticals
Stephen M. Hedrick
Stephen M. Hedrick University of California, San Diego
Ronald H. Schwartz
Ronald H. Schwartz National Institutes of Health
Jeffrey A. Bluestone
Jeffrey A. Bluestone University of California, San Francisco
Yi Wang
Yi Wang Cornell University
Dan L. Longo
Dan L. Longo Harvard University
Gregory L. Stahl
Gregory L. Stahl Brigham and Women's Hospital
Charles A. Janeway
Charles A. Janeway Yale University
William E. Paul
William E. Paul National Institute of Allergy and Infectious Diseases

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their knowledge in Immunology, related online degrees in the healthcare field offer flexible routes to complement and enhance your career. Many professionals are choosing to pursue an online BSN programs for non nurses, designed to help individuals without prior nursing experience transition smoothly into nursing roles.

If you're looking for a faster pathway, accelerated BSN programs for non nurses offer an intensive curriculum that allows students to earn their Bachelor of Science in Nursing degree in a shortened timeframe. These programs are ideal for students eager to enter the healthcare workforce quickly.

For those considering entry-level nursing positions, exploring accredited LPN programs easy to get into can provide a practical and efficient start. Licensed Practical Nurse (LPN) programs typically require less time to complete and pave the way for hands-on patient care roles.

Additionally, if your goal is to advance clinical expertise, easiest NP program options are available to help registered nurses become Nurse Practitioners. These programs focus on specialized skills and can open doors to higher responsibility and better compensation in healthcare settings.

Best Scientists Citing Louis A. Matis

Trending Scientists